# Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support

> **NCT07456670** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Queen's University** · enrollment: 62 (estimated)

## Conditions studied

- Preterm Birth
- Caffeine
- Neonatal Outcomes

## Interventions

- **DRUG:** Caffeine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07456670
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07456670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07456670, "Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT07456670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*